With the Life Sciences Strategy presented in early July 2025, the European Commission aims to position Europe as a globally attractive hub for life sciences by 2030. The strategy sets out a series of measures to be developed and implemented over the coming years. Member States and relevant stakeholders will be involved to ensure efficient use of investment, expertise, and resources. The entire value chain is at the center of the initiative: research and innovation are to be strengthened, market access improved, and trust in life science solutions enhanced.
1) Strengthening Research and Innovation
A pilot project aims to better connect biotech clusters and support start-ups in scaling, with the goal of enhancing the international competitiveness of European biotech innovations. Existing platforms such as the European Cluster Collaboration Platform will be leveraged. A strategic R&I agenda for food systems is also planned, aiming to develop competitive, sustainable, and resilient solutions. This complements the announced strategy for research and innovation in agriculture, forestry, and rural areas stemming from the Vision for Food and Farming.
€200 million from Horizon Europe is earmarked for the development of cross-sectoral life science technologies, including new products (e.g. novel molecules, advanced materials), improved biomanufacturing processes, other industrial biotechnology applications, and the promotion of bioremediation.
Another key focus is on sustainable fermentation technologies, including biomass fermentation. Targeted support for start-ups and SMEs, strengthened public-private partnerships, and knowledge exchange through an annual Advanced Fermentation Conference are planned.
An additional €150 million from Horizon Europe will be invested in research to reinforce Europe’s leadership in the bioeconomy and in sustainable biomass management.
2) Smoother and Accelerated Market Access
To bring biotechnological innovations to market more rapidly, the EU is planning a “Biotech Act” to create an improved regulatory framework for biotech applications across various sectors. In addition, a dedicated matchmaking platform will be established to connect start-ups, industry, and investors, thereby accelerating the commercialisation of new technologies.
3) Public Acceptance and Uptake
Public acceptance of new innovations also plays a pivotal role. To this end, €2 million from Horizon Europe will be allocated for outreach activities. A repository is planned that will provide tools and best practice examples for responsible research, effective risk communication, and targeted public engagement measures led by policymakers and stakeholders.